(Reuters)—The U.S. Food and Drug Administration is strengthening an existing warning label that non-aspirin, non-steroidal antiinflammatory drugs (NSAIDs) increase the risk of heart attack or stroke. NSAIDs include ibuprofen, naproxen, diclofenac and celecoxib, all of which carry FDA warning labels. The agency said it would require updates to the labels of prescription and over-the-counter (OTC)…
Drug Interactions for Trimethoprim/ Sulfamethoxazole Come to Light
Plus, updates on buprenorphine, diclofenac sodium, secukinumab and other rheumatology drug news, safety information
Hydrocodone Bitartrate, Secukinumab, Varenicline Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
10 Tips for Opioid Prescribing
How to manage the risks when prescribing medications for patients in chronic pain
Pediatric Chronic Pain Eased by Early Intervention, Parental Involvement
Comfort Ability program provides psychological strategies to help children self-manage symptoms
Autoimmune Myelofibrosis: A Case Review
Diagnosis, treatment and management of AMF in Hispanic patient with lupus
Rheumatology Drug Updates, Trials, Safety Data
Information on oral anticoagulant apixaban, apremilast for active psoriatic arthritis, hyaluronic acid and methotrexate injections, and drug safety updates rheumatologists need to know
How to Manage Pain in Patients with Renal Insufficiency or End-Stage Renal Disease on Dialysis
Narcotic and non-narcotic pain regimens can be used
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
Pain Treatment Will to Become More Targeted as Knowledge of Pain Mechanics Increases Bad
The notion of pain as just a peripheral, or strictly stimulus-driven, phenomenon is over.